Split History
ETF Investment Portfolio »    AEZS Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AEterna Zentaris is a biopharmaceutical company engaged in the development and commercialization of treatments in oncology and endocrinology. Co.'s pipeline encompasses compounds at all stages of development, from drug discovery through marketed products. Co. benefits from strategic collaborators and licensee partners to contribute to the development of its pipeline of product candidates and to establish commercial activities in specific territories. Co.'s primary business strategy is to finalize the development and pursue registration of Zoptrex™ and Macrilen™ in oncology and endocrinology, respectively. Co.'s products consist of Zoptrex™; Macrilen™; and AEZS-138. According to our AEZS split history records, AEterna Zentaris has had 2 splits.
AEZS split history picture
AEterna Zentaris (AEZS) has 2 splits in our AEZS split history database. The first split for AEZS took place on October 05, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of AEZS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split. AEZS's second split took place on November 20, 2015. This was a 1 for 100 reverse split, meaning for each 100 shares of AEZS owned pre-split, the shareholder now owned 1 share. For example, a 166.666666666667 share position pre-split, became a 1.66666666666667 share position following the split.

When a company such as AEterna Zentaris conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the AEZS split history from start to finish, an original position size of 1000 shares would have turned into 1.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AEterna Zentaris shares, starting with a $10,000 purchase of AEZS, presented on a split-history-adjusted basis factoring in the complete AEZS split history. AEZS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/29/2007
End date: 05/26/2017
Start price/share: $2,250.00
End price/share: $1.18
Dividends collected/share: $0.00
Total return: -99.95%
Average Annual Total Return: -53.01%
Starting investment: $10,000.00
Ending investment: $5.25
Years: 10.00
Date Ratio
10/05/20121 for 6
11/20/20151 for 100
AEZS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AFAM Split History
AFFX Split History
AGN Split History
AHPI Split History
AIMT Split History
AIQ Split History
AIRM Split History
ALBO Split History
ALKS Split History
ALR Split History

Yield10 Bioscience, Inc. (YTEN)
Xerox Corporation (XRX)
Waste Connections, Inc. (WCN)
Spark Energy, Inc. (SPKE)
MagneGas Corporation (MNGA)
Frontier Communications Corporation (FTR)
NeuroMetrix, Inc. (NURO)
Pain Therapeutics, Inc. (PTIE)
Rex Energy Corporation (REXX)
Rexahn Pharmaceuticals, Inc. (RNN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AEZS Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.